Examining a Complex Heart Failure Case
Moderated by Prof Andrew JS Coats, this broadcast explores how a complex heart failure patient would be treated by a multidisciplinary team. In this unique discussion, we examine how the broader heart failure team can work together effectively and consider best practices for referral and initiation of foundational medical therapy.
This programme is supported by an unrestricted educational grant from AstraZeneca.
This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of learning.
Andrew JS Coats
Case Management Discussion
Patient case study summary
Poll results and discussion
Heart Failure Care
Is it always the role of the cardiologist to start HF treatment?
In whom and where can SGLT-2 inhibitors be initiated for HF?
When should SGLT-2 inhibitors be initiated?
- Identify individuals likely to have HFpEF from initial presentation
- Refer suspected individuals for specialist assessment
- Initiate GDMT for HF as soon as patients are stable
- Initiate GDMT in HF regardless of EF and phenotype
- Initiate shared decision-making on complex HF patients with other members of the multidisciplinary team including cardiologists, GPs, nephrologists and diabetologists
- Heart Failure Specialists
- Primary Care Physicians
Dr Silvio Inzucchi is a Professor of Medicine at the Yale University School of Medicine in New Haven, where he serves as Clinical Chief of the Section of Endocrinology, Medical Director of the Yale Diabetes Center, and Program Director of the Endocrinology & Metabolism Fellowship.
Dr Inzucchi has been an invited lecturer both nationally and internationally on many topics, most pertaining to clinical diabetes management. He has authored or co-authored more than 500 manuscripts, chapters, monographs, and abstracts, some published in the most prestigious medical journals, including the New England Journal of Medicine and JAMA.
Richard Hobbs is Professor and Head of Primary Care Health Sciences at the University of Oxford, UK. He is Co-Director of the Quality and Outcomes Review Panel and Deputy Director of the National Institute for Health Research National School for Primary Care Research.
Professor Hobbs serves on numerous scientific boards and is chair of the European Society of Cardiology (ESC) Council of Primary Care, as well as the Prevention and Care Board of the British Heart Foundation (BHF). His publications include 25 book chapters, nine edited books and more than 250 original papers in peer-reviewed journals.
Dr Katherine R Tuttle, is Professor of Medicine in the Nephrology Division and Kidney Research Institute at the University of Washington, US. Executive Director for Research at Providence Inland Northwest Health, and a Co-Principal Investigator for the ITHS. Her major research interests are in the areas of clinical and translational science and precision medicine for diabetic kidney disease, chronic kidney disease, diabetes, and hypertension. Dr Tuttle has led a major patient registry as well as clinical trials in these fields that have delivered breakthrough therapies to prevent kidney failure and cardiovascular events.
Andrew JS Coats
Prof Coats is Editor-in-Chief of the Cardiac Failure Review journal. He has published over 20 patents, more than 750 full research papers and more than 120,000 career citations and has a personal H-index of 146. Andrew was elected to the Presidential Trio of the Heart Failure Association of the ESC in 2018 and will serve as its president from 2020-2022.
Prof Coats is the Immediate past-President of the Heart Failure Association and past-Professor of Cardiology at the University of Warwick, UK. He has also held posts as Head of Cardiology at Imperial College, London and Associate Medical Director and Director of Cardiology at the Royal Brompton and Harefield Hospitals, London. From 2012 to 2017 he was Director of the Monash-Warwick Alliance, and before that served as Deputy Vice-Chancellor and Dean of Medicine at the University of Sydney.
He is an Australian-British academic cardiologist as well as a successful fundraiser, university administrator and inventor. Prof Coats' main interest is heart failure and his current position is Scientific Director at the Heart Institute, Australia.